FindTrial
Sign In

Influence of resveratrol (grappe seed extract) on heart beats at rest and during exercise in adults with hypertension.

Effects of resveratrol supplementation on heart rate variability in adults with hypertension

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2xj368
Enrollment
Unknown
Registered
2016-01-22
Start date
2015-11-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Experimental group: 20 adults with hypertension will take the resveratrol capsules (100 mg) in the morning for 30 days (1 time/day). Control group: 20 adults with hypertension will take the placebo ca
Dietary supplement
D20.215.784.500.400
J02.500.525.425

Sponsors

Instituto Federal de Educação, Ciência e Tecnologia do Sudeste de Minas Gerais
Lead Sponsor
Fabianne Magalhães Girardin Pimentel Furtado
Collaborator

Eligibility

Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adults of both genders, aged between 35-70, with hypertension.

Exclusion criteria

Exclusion criteria: No additional orthopedic deficiencies impairing ambulation Uncontrolled high blood pressure Diabetes or cardiomyopathy Regular wine or grape juice drinkers People who exercise regularly People with intolerance to resveratrol

Design outcomes

Primary

MeasureTime frame
An increase of at least 10% in heart rate variability, verified by heart monitor, in measurements pre and post 30 days of resveratrol supplementation—

Secondary

MeasureTime frame
A reduction of at least 3% in total body fat, verified by tetrapolar electrical bioimpedance, in measurements pre and post 30 days resveratrol supplementation—

Countries

Brazil

Contacts

Public ContactBianca Silveira

Instituto Federal de Educação, Ciência e Tecnologia do Sudeste de Minas Gerais

comunicacao.barbacena@ifsudestemg.edu.br+55 (32) 3693-8612

Outcome results

None listed

Source: REBEC (via WHO ICTRP)